BX-795 inhibits neuroblastoma growth and enhances sensitivity towards chemotherapy
High-risk neuroblastoma (NB) represents a major clinical challenge in pediatric oncology due to relapse of metastatic, drug-resistant disease, and treatment-related toxicities. An analysis of 1235 primary NB patient dataset revealed significant increase in AKT1 and AKT2 gene expression with cancer s...
Guardado en:
Autores principales: | Rameswari Chilamakuri, Danielle C. Rouse, Yang Yu, Abbas S. Kabir, Aaron Muth, Jianhua Yang, Jeffery M. Lipton, Saurabh Agarwal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/876fff3a8ac947789e0b637412ec2d83 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Neuroblastomas en el niño
por: E,BAUZA, et al.
Publicado: (1950) -
PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway
por: Shin Pai, et al.
Publicado: (2021) -
Determination of dose enhancement caused by AuNPs with Xoft® Axxent® Electronic (eBx™) and conventional brachytherapy: in vitro study
por: Shahhoseini E, et al.
Publicado: (2018) -
10 palabras clave sobre racismo y xenofobia
por: Blázquez Ruiz, F. Javier, dir
Publicado: (1996) -
Neuroblastoma de Alto Risco no Uruguai. Onde estamos?
por: Fabiana Morosini, et al.
Publicado: (2018)